Robert P. Mauch
President and Chief Executive Officer
Executive
7 reports
Cencora, Inc. ·COR
Healthcare · Fortune #10 · Functional structure · 46K employees · Conshohocken, PA
Sourced from Cencora, Inc. DEF 14A · filed 2026-01-22 ↗ View on SEC
Interactive org chart
Explore the executive structure, reporting layers, and scenario-ready operating model from public filings.
Choose a prompt, then open an AI app and paste.
Download the CSV data insteadCencora uses a functional executive structure in which two global business presidents report directly to the CEO alongside core corporate functions. This page maps the current leadership team, explains the unusually flat top structure, reviews recent leadership changes, and compares Cencora’s model with key healthcare distribution peers.
What to model
Start with the public baseline, then use the scenario views and source-backed changes to ask what happens when leadership, span, or team ownership shifts.
Announced retirement effective June 30, 2026.
Source · See change logThe people
8 executives identified as Named Executive Officers in the most recent SEC proxy. Bar length scales with tenure.
President and Chief Executive Officer
Executive
7 reports
Executive Vice President and Chief Human Resources Officer
Human Resources
0 reports
Executive Vice President and Chief Legal Officer
Legal
0 reports
Executive Vice President and Chief Financial Officer
Finance
0 reports
Executive Vice President and Chief Strategy and M&A Officer
Strategy
0 reports
Executive Vice President and Chief Data and Information Officer
Technology
0 reports
EVP and President, U.S. Pharmaceuticals and Animal Health
U.S. Operations
0 reports
EVP and President, International Business Group
International
0 reports
The pay
From the most recent DEF 14A Summary Compensation Table. 2 named executive officers disclosed. Bar length scales with total compensation.
The skin in the game
Insider stock holdings and the company's ownership requirements for executives and directors. Disclosed in the most recent DEF 14A.
| Holder | Shares | % of class |
|---|---|---|
| Robert P. Mauch | 115K | <1% |
| James F. Cleary | 146K | <1% |
The businesses
3 divisions report into the group CEO. Tile size scales with estimated headcount.
25K employees
EVP and President, U.S. Pharmaceuticals and Animal Health (Richard Tremonte)
Manages U.S. pharmaceutical and animal health distribution and related services.
15K employees
EVP and President, International Business Group (Juan Guerra)
Oversees pharmaceutical distribution and services outside the United States.
6K employees
President and CEO (Robert P. Mauch)
Includes finance, legal, HR, strategy, and enterprise technology functions.
The thesis
Cencora’s most distinctive feature is that its two geographic business presidents report directly to the CEO alongside functional chiefs.
This places full P&L ownership for the U.S. and International businesses at the same level as Finance, HR, Legal, Strategy, and Technology. The structure emphasizes functional scale and control rather than creating multiple divisional CEOs.
The CEO’s span of control is relatively wide, with eight direct reports covering both operations and corporate functions. Notably, there is no standalone COO role; operational accountability sits with the two regional presidents. This reinforces a functional operating model with strong central oversight, typical of large healthcare distributors.
Compared with peers, Cencora’s leadership team is compact for a Fortune 10 company, reflecting a preference for centralized decision-making and limited management layers at the top.
The comparison
Relative to peers such as McKesson and Cardinal Health, Cencora runs a similarly functional model but with fewer C-suite roles dedicated to technology or innovation. Unlike some peers, it separates U.S. and International P&L leadership explicitly at the EVP level. The absence of a COO contrasts with Cardinal …
Current signals
The most significant change is the announced retirement of CFO James F. Cleary effective June 30, 2026.
Announced retirement effective June 30, 2026.
SourceYear-over-year executive structure based on SEC proxy and annual filings.
First full year with Mauch as CEO following Collis transition.
CEO succession announced with Mauch designated successor.
Stable long-tenured leadership under Collis.
The CEO transition to Mauch reduced average executive tenure and slightly expanded the CEO’s span.
Robert P. Mauch has served as President and CEO since October 2024.
Cencora uses a primarily functional structure with centralized corporate functions.
The CEO currently has eight direct reports.
In March 2026, CFO James F. Cleary announced his retirement effective June 30, 2026.
No, Cencora does not have a COO; operations are led by the U.S. and International presidents.
Reference
If you reference this page in research, analysis, or news writing, use one of the formats below. Citation includes the SEC filing source where applicable.
Creately. (2026). Cencora, Inc. organizational structure. Creately. Retrieved , from https://creately.com/org-chart/fortune-500/cencora/"Cencora, Inc. Organizational Structure." Creately, April 1, 2026, https://creately.com/org-chart/fortune-500/cencora/. Accessed .Creately. "Cencora, Inc. Organizational Structure." Last modified April 1, 2026. https://creately.com/org-chart/fortune-500/cencora/.Cencora, Inc.. DEF 14A. Filed 2026-01-22. U.S. Securities and Exchange Commission. https://www.sec.gov/Archives/edgar/data/1140859/000162828026003061/cor-20260122.htmPermanent URL: https://creately.com/org-chart/fortune-500/cencora/ · last updated 2026-04-01